ARBs help keep Alzheimer's at bay

Angiotensin II receptor blockers can slow the progression of Alzheimer's disease - and even stave it off outright - compared with other antihypertensive agents, an autopsy study suggests.

The study of 890 brains from people with hypertension found those who had taken ARBs were up to 35% less likely to receive a neuropathological diagnosis of Alzheimer's disease, compared with those treated with other antihypertensives.

There was also significantly less amyloid deposition in the brains of patients